Aims: Prion diseases are generally characterized by pronounced neuronal loss. In particular, a subpopulation of inhibitory neurones, characterized by the expression of the calcium-binding protein parvalbumin (PV), is selectively destroyed early in the course of human and experimental prion diseases. By contrast, nerve cells expressing calbindin D28k (CB), another calcium-binding protein, as well as PV/CB coexpressing Purkinje cells, are well preserved. Methods: To evaluate, if PV and CB may directly contribute to neuronal vulnerability or resistance against nerve cell death, respectively, we inoculated PV-and CB-deficient mice, and corresponding controls, with 139A scrapie and compared them with regard to incubation times and histological lesion profiles. Results: While survival times were slightly but significantly diminished in CB-/-, but not PV-/-mice, scrapie lesion profiles did not differ between knockout mice and controls. There was a highly significant and selective loss of isolectin B 4-decorated perineuronal nets (which specifically demarcate the extracellular matrix surrounding the 'PVexpressing' subpopulation of cortical interneurones) in scrapie inoculated PV+/+, as well as PV-/-mice. Purkinje cell numbers were not different in CB+/+ and CB-/-mice. Conclusions: Our results suggest that PV expression is a surrogate marker for neurones highly vulnerable in prion diseases, but that the death of these neurones is unrelated to PV expression and thus based on a still unknown pathomechanism. Further studies including the inoculation of mice ectopically (over)expressing CB are necessary to determine whether the shortened survival of CB-/-mice is indeed due to a neuroprotective effect of this molecule.
Introduction
Prion diseases are fatal neurodegenerative disorders of infectious, inherited or sporadic origin. They occur in humans as Creutzfeldt-Jakob disease, GerstmannSträussler-Scheinker disease, fatal familial insomnia and kuru, as well as in animals, like scrapie in sheep and bovine spongiform encephalopathy in cattle [1] . Damage to the central nervous system in prion diseases is typically characterized by a triad comprising spongiform change, astrogliosis and neuronal loss. In addition, an abnormal, partially protease-resistant isoform [(pathological isoform of the prion protein (PrP Sc )] of the cellular prion protein (PrP C ) accumulates mainly in the brain of affected individuals. Neither the precise nature of the infectious agent nor the central nervous pathomechanisms have so far been fully elucidated [2] [3] [4] .
In an attempt to characterize increased susceptibility or resistance of distinct neuronal subpopulations to prionrelated neurodegeneration, we previously determined the survival of calbindin D28k (CB) and parvalbumin (PV) containing neurones in different types of prion diseases. We found an early, selective and severe, but incomplete loss of PV-positive inhibitory interneurones in the frontal, temporal and entorhinal cortex, and in the preparasubiculum in humans, as well as in the retrosplenial granular cortex in mice, while CB expressing interneurones, like PV/CB coexpressing Purkinje cells, were well preserved [5] [6] [7] .
Parvalbumin and CB, which belong to the EF-hand family of calcium-binding proteins, are thought to mainly serve as cytosolic calcium buffers, but for CB additional roles as a calcium sensor have been reported [8] . In the brain, they are expressed in specific, mainly nonoverlapping subsets of neurones [9, 10] . The exact mode of how these proteins modify temporal and spatial aspects of Ca 2+ transients to maintain intracellular Ca 2+ homeostasis remained obscure until knockout mice were generated [9, 11] . Most surprisingly, null mutant strains (CB-/-and PV-/-) show a normal development in terms of life span, growth, fertility, physical activity and behaviour, under standard housing conditions [9, 11, 12] ; in specific test cages, however, subtle alterations in locomotor activity have recently been reported for both genotypes [13] . Furthermore, on the light microscopic level, no differences in brain morphology were observed at any age between mutant and wild-type mice [9, 12] . Due to their Ca 2+ -buffering capacity, CB and PV have been discussed to influence survival or death of neurones under pathological conditions that are combined with a rapid increase of the intracellular Ca 2+ load, either as neuroprotective molecules or as factors selectively increasing neuronal vulnerability. However, no generalized relationship between the expression of a specific calcium-binding protein on one hand, and its protective or antiprotective role on the other hand, has so far been established.
In prion diseases, PV may directly contribute to neuronal vulnerability, and CB, vice versa, to the resistance against nerve cell death, by as yet unknown mechanisms. To evaluate a possible causal relationship, we inoculated PV-and CB-deficient mice, as well as corresponding controls, with the 139A scrapie strain and compared them with regard to incubation times and histological lesion profiles, the latter comprising spongiform change, astrogliosis and PrP Sc deposition. In addition, the loss of cortical 'PV-interneurones' (that is interneurones that would normally contain PV) was quantified in PV knockout mice, and the general survival of Purkinje cells was analysed in CB-deficient animals, both in comparison with the respective control mice.
Materials and methods

Animals and housing conditions
The experimental set-up was approved by the national animal welfare committee at the federal ministry of health and women, Vienna. In the present experiment, 16 adult female PV-/-mice and 12 PV+/+ animals, as well as 26 adult female CB-/-mice and 13 CB+/+ animals were used. Generation and initial characterization of these null mutant strains of mice are described in detail elsewhere [9, 11] . Homozygous breeding pairs for PV+/+ and PV-/-mice both had a mixed 129/OlaHsd (129P2) ¥ C57BL/6J (B6) genetic background [11] , while the breeding pairs for CB+/+ and CB-/-mice were based on a mixed 129R1 ¥ B6 genetic background [9] . The animals were maintained under standard conditions (that is artificial day-night cycle with light from 6 a.m. to 6 p.m.; constant temperature/humidity). Separated according to their strain, mice were kept in groups of two to three animals in type II cages. In three independent sessions, 12 PV-/-and six PV+/+ mice (age 10-11 weeks), as well as 17 CB-/-and seven CB+/+ mice (age between 9 and 13 weeks) were inoculated intracerebrally (i.c.) with 30 ml of the 139A scrapie strain (provided by M. Groschup, Riems, Germany) at a 1:100 dilution. Concomitantly, four PV-/-, six PV+/+, nine CB-/-and six CB+/+ control animals were inoculated (i.c.) with 30 ml of noninfectious brain homogenate (mock) at the same dilution. To allow standardized sampling of brain tissue and, at the same time, determination of survival times in scrapie inoculated mice, spontaneous death was awaited in those animals, which were the first to develop the disease in each experimental group (that is one PV+/+, four PV-/-, three CB+/+ and six CB-/-mice), while all other animals were killed with CO 2 at the ultimate disease stage, where spontaneous death was expected to occur within less than a day. Of the scrapie inoculated CB-deficient mice, one animal died of an intercurrent infection 116 days after inoculation prior to the development of clinical symptoms of scrapie and was therefore excluded from further analysis. Controls were killed several days after the last scrapie animal of the respective experimental group. After death, animals were immediately perfused transcardially with 20 ml phosphate buffered saline (PBS), followed by 20 ml 4% buffered formalin. Subsequently, brains were removed, post-fixed for 24 h in 4% formalin and rinsed in PBS for several days. Coronal slices of forebrain and cerebellum were embedded in paraffin. For haematoxylin-eosin staining and immunohistochemical analysis, 4-mm sections were prepared.
Immunohistochemistry and staining of perineuronal nets (PNN)
For immunohistochemical analyses, monoclonal antibodies against CB-D28k (clone CL-300; Sigma-Aldrich Co., St Louis, MO, USA; dilution 1:50), PV (clone PA-235; SigmaAldrich Co.; 1:5000) and PrP (clone 6H4; Prionics AG, Schlieren-Zürich, Switzerland; 1:500), as well as a polyclonal antibody against glial fibrillary acidic protein (GFAP, Dako, Glostrup, Denmark; 1:3000), were applied. Peroxidase-labelled isolectin B 4 (ILB4) from vicia villosa (10 mg/ml in Tris buffered saline; Sigma-Aldrich Co.; 1:100) was used to decorate perineuronal nets (PNN). Pretreatment of paraffin sections included antigen retrieval by steaming for 60 min in citric acid buffer, pH 6.0 (CB, ILB 4), antigen retrieval followed by incubation in concentrated formic acid for 2 min (PV), and digestion with 0.3 mg/ml protease type XXIV (Sigma-Aldrich Co.) in PBS for 10 min at 37°C (GFAP). Staining of PrP Sc was performed with a three-step pretreatment protocol comprising hydrated autoclaving, incubation in concentrated formic acid and, subsequently, in guanidine isothiocyanate. Primary antibodies were diluted in a detergentcontaining diluent (Dako) and incubated overnight at 4°C. The ChemMate TM Detection Kit (Dako) was used for visualization according to the manufacturer's protocol. The specificity of primary antibodies was verified by appropriate serum and isotype controls. For lectin staining, sections were incubated with peroxidase-labelled ILB 4 for 1 h at 37°C and developed with diaminobenzidine.
Lesion profiling
Classical mouse scrapie lesion profiles (degree of spongiform change in the neuropil and white matter tracts, as well as neuronal vacuolation) were determined according to the method described by Fraser and Dickinson [14] and Bruce et al. [15] . Briefly, vacuolar degeneration was scored on a scale of 0 (no vacuolar degeneration) to 5 (massive, confluent vacuolation with an average number of 300-400 vacuoles per analysed microscopic field) in nine defined grey matter and three white matter areas (for details see legend of Figure 2 ) using a Nikon photomicroscope equipment (microscope: Nikon Eclipse E600, objective: Nikon Plan Apo 40 ¥/0.95 DIC M; Nikon corporation, Tokyo, Japan). In order to assess predefined brain areas properly, an average score for 2-6 neighbouring high power fields (field size 200 ¥ 140 mm) was determined for each of the brain regions. Apart from the analysis of spongiform degeneration, we also investigated the extent and distribution of PrP Sc deposition and gliosis semiquantitatively in the same grey matter areas that were used for the classical lesion profiling. For this purpose, we used the following scores: (i) PrP Sc : 0 (no deposition), 1 (mild deposition), 2 (moderate deposition) and 3 (massive deposition); (ii) GFAP: 0 (no astrogliosis), 1 (single reactive fibrillary astrocytes within the neuropil), 2 (moderate number of reactive fibrillary astrocytes), 3 (moderate to high number of reactive fibrillary astrocytes and strong background of GFAP positive astrocytic processes in the neuropil), 4 (high number of reactive astrocytes with transition features towards gemistocytic astrocytes) and 5 (high number of highly reactive gemistocytic astrocytes) (representative pictures for GFAP and PrP Sc are provided as electronic supplementary material in Figures S1 and S2 respectively).
The number of normally PV-expressing cortical interneurones was quantified by light microscopy (Nikon Plan Apo 60 ¥/0.95 DIC M) in scrapie, as well as mock, inoculated PV-/-and PV+/+ mice by counting nerve cells surrounded by ILB 4-decorated PNN in the agranular and granular retrosplenial cortex of both hemispheres at the level of the thalamus (brain areas according to Paxinos and Franklin [16] ). Only neurones with clearly visible cytoplasm and nucleus were included in the statistical evaluation.
Finally, the density of Purkinje cells was analysed in scrapie infected CB-/-and CB+/+ mice by determining the total number of Purkinje cells, as well as the average number of Purkinje cells per high power field, in 20 high power fields (field length 147 ¥ 103 mm) in the second and third cerebellar lobule (later referred to as region A) and 12 high power fields in the lateral portion of the third and fourth cerebellar lobules, the simple lobule, and crus 1 of the ansiform lobule (later referred to as region B) using a 60¥ objective (brain areas see [16] ). All assessments were performed in a diagnosis-blinded fashion.
Statistics
Significances of differences in survival times between different groups of animals were evaluated with the log rank test. The number of ILB 4-decorated PNN in scrapie and mock inoculated PV+/+ and PV-/-mice, as well as the density of Purkinje cells in the cerebellar cortex in scrapie and mock inoculated CB+/+ and CB-/-mice were compared by means of the Mann-Whitney test. Statistical analyses were carried out with the spss 10.0 (SPSS Inc., Chicago, IL, USA) and the StatGraphics 4.0 software (StatPoint, Inc., Herndon, VA, USA).
Results
Survival times are diminished in scrapie inoculated CB-/-mice as compared with controls
Deficiency for CB shortened survival after infection with scrapie prions to a small, but highly significant degree. Scrapie infected CB+/+ mice died at 160.0 Ϯ 3.1 days (mean Ϯ standard deviation), while scrapie inoculated CB-/-mice only survived for 150.4 Ϯ 6.7 days after i.c. inoculation (P = 0.0002; Figure 1B ). Of note, all except one CB knockout mice had died or had to be sacrificed as a result of progression to the final disease stage before the first control died due to scrapie ( Figure 1B) . By contrast, the presence or absence of PV did not significantly influence survival times in scrapie animals. PV+/+ mice died at 156.2 Ϯ 9.8 days, PV-/-mice at 159.1 Ϯ 7.9 days after inoculation (P = 0.62; Figure 1A ).
Scrapie lesion profiles do not differ between CB-/-, as well as PV-/-mice and their respective controls
Evaluating the classical lesion profile, which describes the degree of spongiform change in neuropil and nerve cells [14, 15] , we did not observe a significant difference between scrapie infected PV-or CB-deficient mice and their respective wild-type controls (Figures 2A,D and  3A ,D,G,K). The lesion profile in all groups was consistent with the 'reference profile' reported by Bruce et al. [15] . Noteworthily, in the grey matter, lesion scores were in most instances higher in the rostral part of the brain (scoring positions 5-9; Figure 2A ,D) as compared with the more caudal parts (scoring positions 1-4, Figure 2A ,D). The highest scores were found in the thalamus, the paraterminal body and the anterior paramedian cerebral cortex (positions 5, 7, 9), while the lowest score was present in the cerebellar cortex (position 2). Sc deposition (C,F). Blue lines in (B) and (E) illustrate the combined scores for reactive gliosis in mock-inoculated PV-/-and PV+/+(B), as well as CB-/-and CB+/+(E) healthy control mice. Note the relatively high control scores in the hypothalamus (4) and hippocampus (6), the latter presumably pioneering the peak scores in this area in the related scrapie infected animals. Analysed grey matter areas included: 1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 4 hypothalamus; 5, medial thalamus; 6 hippocampus; 7, paraterminal body; 8, posterior medial cerebral cortex at the level of the thalamus; 9, anterior medial cerebral cortex at the level of the paraterminal body (A-F). Analysed white matter areas included: 1*, cerebellar white matter; 2*, white matter of the mesencephalic tegmentum; 3*, pyramidal tract (A,D) [14, 15] .
When we determined the degree of astroglial activation in the same grey matter areas as defined for the classical lesion profile, we again did not detect any significant differences between all groups of scrapie inoculated mice (Figures 2B,E and 3B,E,H,L). As in the classical lesion profile, we observed a tendency for the degree of astrogliosis to be enhanced in the rostral areas of the brain (scoring positions 5-9) as compared with the caudal part (scoring positions 1, 2 and 4; Figure 2B ,E). While the lowest score was again detected in the cerebellar cortex (position 2), the highest scores were found in the hippocampus and the posterior paramedian cerebral cortex at the level of the thalamus (positions 6 and 8). Importantly, mock inoculated animals show a low to medium degree of astroglial activation in the hippocampus and the hypothalamus (positions 6 and 4, Figure 2B ,E: blue line; Figure 3O) ; therefore, the peak score in the hippocampus in scrapie infected mice most likely represents an artefact due to the intracerebral inoculation route.
Finally, scoring of PrP Sc deposition in the previously established grey matter areas [14] did not reveal any significant difference between scrapie infected animals of all genotypes ( Figures 2C,F and 3C,F,I ,M). Higher scores were again found in the rostral (positions 6-9), lower scores in caudal brain areas (positions 1-4, Figure 2C ,F).
Highly significant, selective loss of ILB4-decorated PNN in scrapie inoculated PV+/+, as well as PV-/-, mice
In control mice, the average number of ILB4-decorated PNN (which specifically demarcate PV-positive cortical interneurones) in the retrosplenial cortex of one hemisphere dropped from 44.4 in mock injected healthy animals to 24.4 in scrapie inoculated mice, equivalent to a loss of 45.0% of PV-expressing inhibitory interneurones ( Figure 4A,B,D) . In PV-deficient mice, the average number of ILB 4-decorated PNN decreased from 42.0 in mock inoculated controls to 25.8 in scrapie infected mice, corresponding to a loss of 38.6% of 'PV-interneurones' (Figure 4A,C) . Statistical analysis revealed a highly significant difference in the average number of PNN between scrapie and mock inoculated PV+/+ mice (P = 0.0003), as well as between scrapie and mock inoculated PV-/-animals (P = 0.0006), but no significant difference between scrapie infected PV+/+ and PV-/-animals (P = 0.63), or mock inoculated PV+/+ and PV-/-mice (P = 0.13) respectively. Figure 5A,B,D) .
No significant difference in Purkinje cell numbers between scrapie inoculated CB+/+ and CB-/-mice
Discussion
The principal results of our study are: (i) deficiency for CB in scrapie inoculated mice results in a small, but highly significant reduction of survival time, but does not influence the general cerebral lesion profile, nor the extent of degeneration of cerebellar Purkinje cells, in the terminal stage of the disease; and (ii) deficiency for PV does not alter survival time, general cerebral lesion profile or degree of selective degeneration of cortical interneurones surrounded by PNN in mice experimentally challenged with scrapie prions.
Previous demonstrations of an early, selective and severe loss of inhibitory, GABAergic interneurones containing the calcium-buffer PV [5] [6] [7] 17, 18 ] raised speculations about a potential contribution of PV to the degeneration of this particular subset of interneurones by so far unknown mechanisms. The present study shows that PV expression, at least at expression levels observed in wild-type mice, is not causally related to neurodegeneration in prion diseases. At the global level, PV-deficiency changes neither the survival time, nor the general lesion profile in scrapie inoculated animals ( Figures 1A, 2A -C and 3A-F). And most importantly, the degeneration of vulnerable interneurones in murine scrapie is neither increased nor decreased in PV-deficient mice (Figure 4) , implicating that PV deficiency does not protect from -and vice versa, PV expression does not contribute to -prioninduced neuronal cell death. This is also supported by the results obtained from prion inoculated CB-/-mice. In this particular mouse strain, cerebellar Purkinje cells contain high amounts of PV as the only, or at least major, remaining calcium binding protein known [10] ; nevertheless, they are resistant to prion-related cell death to the same degree as in scrapie infected CB+/+ controls ( Figure 5 ) indicating again that PV expression per se does not promote prion-related neurodegeneration. It therefore seems that PV expression merely coexists with one or more factors responsible for selective neuronal vulnerability. It has been speculated that PNN, the specifically composed extracellular matrix around neocortical and hippocampal PV containing interneurones, might harbour such a factor contributing to the increased susceptibility, especially as Purkinje cells, which are not surrounded by PNN, are quite resistant against prion-related neurodegeneration [7] . In line with this idea, Belichenko et al. reported that the loss of PNN precedes the degeneration of PV-immunoreactive interneurones [17] ; the authors concluded that PNN are destroyed due to an interaction between PrP C and/or PrP Sc and components of this extracellular matrix, and that they are finally replaced by PrP Sc deposits. This switch in cellular environment eventually initiates the death of PV-positive interneurones [17] . Another more recent report suggests that PrP Sc does not interact directly with PNN, but withdraws a factor critical for prion conversion as well as for maintenance of this extracellular matrix, thereby destabilizing PNN. Subsequently, the nets degenerate, initiating again the loss of PV-containing interneurones [19] . Both hypotheses could explain the fact that the loss of PNN slightly precedes and exceeds the loss of PV-positive interneurones, but not the variability regarding the degree of survival or loss of nets and neurones: in experimental prion diseases, only about half of the PV-containing cortical interneurones surrounded by PNN degenerate, while the remaining survive until the animals reach the terminal disease stage. Thus, it may well be that PNN, like PV expression, only represent a surrogate marker for interneurones vulnerable to prion diseases, but that the death of these neurones is based on a still unknown pathomechanism.
Concerning the results obtained from CB knockout mice, the significantly shortened survival time of scrapie inoculated animals ( Figure 1B On the other hand, the decreased survival time of CB-/-mice does not necessarily reflect a mere loss of neuroprotection. As was mentioned in the Introduction, CB knockout mice behave completely normally under physiological conditions in their home cage, whereas in specific locomotor tests, they show a significant impairment of Purkinje cell-dependent motor coordination resulting in an ataxic phenotype [9, 13] . These observations have recently been confirmed in a Purkinje cell-specific CB null mutant mouse strain [20] . Impaired motor coordination is also a central part of the clinical picture observed in murine scrapie. Hence, the slightly shortened survival time of CB-/-mice might be explained by three scenarios: (i) a true, albeit small neuroprotective effect of CB; as the expression pattern of CB is restricted to subpopulations of interneurones, this hypothetical loss of protection in CB-/-mice would have a limited impact only, explaining the fairly small difference in survival time between CB-/-and CB+/+ animals; (ii) a mutual interaction between clinical scrapie and a 'stressinduced' CB-/-phenotype; in this case, synaptic damage and nerve cell dysfunction, both developing in the course of the prion disease, might be aggravated by motor coordination deficits due to CB deficiency; this could result in a more severe and more rapid disease phenotype, decreasing the time until the mice reach the terminal disease stage; and (iii) a combination of (i) and (ii). A cautious interpretation is also necessary regarding the unaltered number of surviving Purkinje cells in CB-/-mice. Several compensatory mechanisms induced in CB-/-Purkinje cells have been reported, which were discussed as homeostatic mechanisms of these neurones to cope with the absence of CB: (i) the length of spines was increased [21] ; and (ii) the modelled Ca 2+ extrusion rate in CB-/-dendritic spines had to be increased twofold in comparison with CB+/+ spines in order to accurately fit the experimental data of spine Ca 2+ transients, suggesting an up-regulation of proteins involved in Ca 2+ extrusion [22] . Interestingly, no up-regulation of PV, the other prevalent Ca 2+ buffer of Purkinje cells, was observed in cerebellar extracts of CB-/-mice [9] . Thus, the unchanged resistance of Purkinje cells of CB-/-mice against prion-induced cell death in this study does not allow the drawing of a general conclusion on CB's putative neuroprotective effect in prion diseases. However, in a recent study, a pronounced increase in corticosteroid levels was reported in the clinical stage of murine scrapie [23] . Elevated corticosteroid levels, in turn, are known to induce CB expression, at least in hippocampal neurones in rodents and primates [24] [25] [26] with a significant impact on selective neuronal survival in a rodent model of cerebral ischemia [27] . Of note, a majority of experiments (in vitro, but also in vivo) investigating the potential protective function of CB revealed a positive effect against excitotoxic stimuli (e.g. as discussed in [28] [29] [30] ), while, on the other hand, studies using CB-deficient mice did not show any significant protection against neuronal injury [31] [32] [33] .
Collectively, our current results studying scrapieinfected CB-/-mice do not permit the drawing of a final conclusion on a potential neuroprotective role of CB in prion diseases. The shortened survival time of scrapieinfected CB-/-mice is generally in accordance with a neuroprotective effect of CB but does not prove it due to the possible interference with a CB-/-phenotype; the unaltered lesion profiles in terminally sick CB-/-mice, on the other hand, do not corroborate a neuroprotective function of CB, although the analysis of semiquantitative lesion profiles might be too insensitive to disclose minimal changes when used in a loss of function model restricted to a limited number of neurones only. Further experiments including the inoculation of mice ectopically (over)expressing CB in most neurones -on a constitutive or inducible basis -should allow to further dissect CB's possible protective influence on neuronal survival in prion diseases.
